Latest Period
Q1 2026
Security Snapshot
Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI) Institutional Ownership
CUSIP: 320703408
13F Institutional Holders and Ownership History from Q3 2025 to Q2 2026
Institutions Reporting
27
Shares (Excl. Options)
2,007,879
Price
$0.24
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Symbol
- CLDI on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 2,007,879
- Total 13F value
- $478,788
- Portfolio coverage rank
- 0%
- Share change
- +1,559,557
- Value change
- +$226,762
- Number of holders
- 27
- Shares outstanding
- 7,142,857
- SEC-reported price per share
- $0.13
- Insider filing price
- $0.13
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CLDI - Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value is tracked under CUSIP 320703408.
- 27 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 27 to 8 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $478,788 to $13,107.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 27 institutions filings for Q1 2026.
Security key
320703408
Latest holder period
Q1 2026
13F holders
27
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
CLDI full holder history
Calidi Biotherapeutics, Inc. SEC filings
Calidi Biotherapeutics, Inc. company facts
Calidi Biotherapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 320703408:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
CLDI
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 5% | 117,368 | Armistice Capital, LLC | 30 Jun 2025 | ||||
| Gavrilov Ognian Anguelov | 0.3% | -95% | $6,600 | -$224,400 | 20,000 | -97% | Gavrilov Ognian Anguelov | 31 Mar 2026 |
As of 31 Mar 2026, 27 institutional investors reported holding 2,007,879 shares of Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI). This represents 28% of the company’s total 7,142,857 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
28%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 12% | 879,000 | 0.01% | $209,905 | |
| SABBY MANAGEMENT, LLC | 6.1% | 434,903 | 1.8% | $103,855 | |
| Warberg Asset Management LLC | 3.5% | 250,000 | 0.02% | $59,475 | |
| HighTower Advisors, LLC | 1.2% | 83,523 | 0% | 0% | $19,945 |
| Virtu Financial LLC | 1.1% | 75,769 | +257% | 0% | $18,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.88% | 63,019 | +50% | 0% | $15,048 |
| RS CRUM INC. | 0.56% | 40,256 | +99% | 0% | $9,614 |
| Arax Advisory Partners | 0.52% | 37,345 | 0% | $8,918 | |
| JANE STREET GROUP, LLC | 0.49% | 34,802 | +203% | 0% | $8,311 |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.36% | 25,509 | 0% | 0% | $6,097 |
| Belpointe Asset Management LLC | 0.28% | 19,921 | -0.25% | 0% | $4,757 |
| NORTHERN TRUST CORP | 0.25% | 17,758 | 0% | 0% | $4,241 |
| HRT FINANCIAL LP | 0.14% | 10,133 | 0% | $2,000 | |
| Farther Finance Advisors, LLC | 0.14% | 10,000 | 0% | 0% | $2,426 |
| MORGAN STANLEY | 0.13% | 9,467 | +545% | 0% | $2,261 |
| VANGUARD FIDUCIARY TRUST CO | 0.13% | 9,219 | 0% | 0% | $2,203 |
| OSAIC HOLDINGS, INC. | 0.03% | 2,106 | 0% | 0% | $503 |
| Tower Research Capital LLC (TRC) | 0.02% | 1,396 | -50% | 0% | $333 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0.01% | 1,042 | 0% | 0% | $248 |
| Finepoint Capital LP | 0.01% | 1,042 | 0% | 0% | $249 |
| Apollo Management Holdings, L.P. | 0.01% | 1,042 | 0% | 0% | $249 |
| FMR LLC | 0% | 255 | -99% | 0% | $61 |
| SBI Securities Co., Ltd. | 0% | 115 | +150% | 0% | $27 |
| Tradewinds Capital Management, LLC | 0% | 101 | 0% | 0% | $25 |
| Reyes Financial Architecture, Inc. | 0% | 100 | 0% | 0% | $24 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Latest
Q1 2026
Rows shown
1-4 of 4